Publication | Closed Access

Diaryl sulfide analogs of combretastatin A-4: Toxicogenetic, immunomodulatory and apoptotic evaluations and prospects for use as a new chemotherapeutic drug

Medicinal ChemistryMedicineNew Chemotherapeutic DrugPharmacotherapyAnti-cancer AgentMetronomic ChemotherapyApoptotic EvaluationsDrug DevelopmentPharmacologyRadiation OncologyDiaryl Sulfide AnalogsDrug Discovery